Overview
Financials
Revenue history (in k)
Financial insight
- The statement flags a going concern risk. W dniu 24.03.2025 Kierownik jednostki podjął decyzje o braku kontynuowania działalności przez Spółkę. Rozpoczęto proces wygaszania działalności Spółki, który w końcowym etapie doprowadzi do formalnego otwarcia likwidacji Spółki a następnie jej likwidacji. Na podstawie tej decyzji sprawozdanie finansowe sporządzone zostało przy braku założenia kontynuacji działalności. Przy tworzeniu sprawozdania finansowego Spółka stosowała zasady określone przepisami Ustawy z dnia 29 września 1994 roku o rachunkowości (tekst jednolity - Dz.U. z 2023 r., poz 120, z późniejszymi zmianami) w szczególności art. 29 oraz Krajowy Standard Rachunkowości numer 14.
From the notes
| Current income tax (CIT due) | $0 |
Filing timeliness
1 of 6 financial statements was filed late (for 2025, 1 day late). 4 of 6 audited by a statutory auditor.
- 202516/07/2026
- 202403/07/2025
- 202308/07/2024
- 202228/06/2023
- 202125/05/2022
- 202003/09/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Authorized Representatives
Manner of representation
President of the Management Board independently (one-person representation). In the event of the appointment of a multi-member management board, the joint action of two members of the management board, or of one member of the management board jointly with a commercial proxy, is required.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Bausch+lomb Netherlands B.v. | 100 | $2,701,242.57 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 1997-01-01.
43 1030 1508 0000 0008 1769 2029- 26 1030 1508 0000 0008 1769 2044
- 48 1030 1508 0000 0008 1769 2036
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $231.4K$231,356 |
Buildings and premises | $1.6M$1,573,872 |
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | Waste generation | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Poldentsp. z o.o. | $9,440,759.21 | poldent.pl | ||
| Metzer Medizin- Und Industrietechniksp. z o.o. | $1,511,723.18 | metzer.pl | ||
| Endotradesp. z o.o. | $912,862.33 | endotrade.pl | ||
| Your Labsp. z o.o. | $198,230.62 | yourlab.pl | ||
| PhilabsS.A. | $64,403.10 | phibox.eu | ||
| IDL Polandsp. z o.o. | $43,351.03 | idlpoland.com | ||
| Milton EssexS.A. | $40,863.48 | miltonessex.eu | ||
| NEO Ortho Pracownia Sztuki Ortopedycznejsp. z o.o. | $5,662.74 | neoortho.pl | ||
| Bioimplantisp. z o.o. | $1,660.39 | bioimplanti.pl | ||
| Royal Methodsp. z o.o. | $1,089.26 | royal-method.com |
Change history
| Date | Event | |
|---|---|---|
| 2026-05-14 | Address change (Ryżowa 31, 02-495, Warszawa → Ul. Marynarska 15, 02-674, Warszawa) | |
| 2015-04-03 | Name change (Croma Polska → Valeant Med) | |
| 2015-04-03 | PKD change (Removed: 28 codes) | |
| 2010-11-08 | Name change (Laboratorium Corneal-Polska → Croma Polska) | |
| 2010-11-08 | Switch to PKD 2007 (22 PKD 2004 codes → 38 PKD 2007 codes) |
FAQ
Last updated: 2026-10-07